Evidence map›Paper›PMID 40513563›Full record

ReviewAmerican journal of human genetics2025

A data model for population descriptors in genomic research.

Alyna T Khan, Clement Adebamowo, Stephanie M Fullerton, Jibril Hirbo, Iain R Konigsberg, Peter Kraft, Iman Martin, Sarah C Nelson, Michèle Ramsay, Genevieve L Wojcik and 16 more

Abstract readReview
In one paragraph

Review in American journal of human genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Continuity Trap in Data Science Health Research.Journal of medical Internet research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Alyna T KhanSchool of Engineering, Design, and Innovation, Pennsylvania State University, University Park, PA, USA. Electronic address: atk43@psu.edu.
Clement AdebamowoDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Stephanie M FullertonDepartment of Bioethics & Humanities, University of Washington, Seattle, WA, USA.
Jibril HirboDepartment of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Iain R KonigsbergDepartment of Biomedical Informatics, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA.
Peter KraftDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Iman MartinDivision of Genomic Medicine, National Institutes of Health, Bethesda, MD, USA.
Sarah C NelsonDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Michèle RamsaySydney Brenner Institute for Molecular Bioscience, University of the Witwatersrand, Johannesburg, South Africa.
Genevieve L WojcikDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sally N AdebamowoDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Matthew P ConomosDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Burcu F DarstFred Hutchinson Cancer Center, Seattle, WA, USA.
Micah R HysongDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yun LiDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Alicia R MartinAnalytic & Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA; Medical and Population Genetics Program, Broad Institute, Boston, MA, USA.
Rasika A MathiasLaboratory of Allergic Diseases/Genomics and Precision Health Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Stephen S RichDepartment of Genome Sciences, University of Virginia, Charlottesville, VA, USA.
Lori C SakodaDivision of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.
Daniel R SchriderDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jayati SharmaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Johanna L SmithDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Quan SunDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yuji ZhangDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium
Stephanie M GogartenDepartment of Biostatistics, University of Washington, Seattle, WA, USA. Electronic address: sdmorris@uw.edu.

Funding

The AnVIL Data Ecosystem DACReS SupplementU24HG010262 · NHGRI · BROAD INSTITUTE, INC. · PI Robert J Carroll, Jonathan Lawson · 2018 to 2026
$40.5M
Polygenic Risk Score Methods Development Consortium Coordinating CenterU01HG011697 · NHGRI · UNIVERSITY OF WASHINGTON · PI Kenneth M. Rice · 2021 to 2026
$8.8M
CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Multiple AncestriesU01HG011723 · NHGRI · BROAD INSTITUTE, INC. · PI Alisa Knodle Manning, Josep Maria Mercader · 2021 to 2026
$5.7M
Enabling improved applicability and transferability of polygenic scores across populationsU01HG011719 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI Alicia Martin · 2021 to 2026
$5.5M
Polygenic risk scores for cardiometabolic disorders: the role of blood cells immune response and evolutionary adaptationU01HG011720 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yun Li, ALEXANDER P REINER · 2021 to 2026
$5.4M
PRS Center for Admixed Populations (CAPE)U01HG011715 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Eimear Elizabeth Kenny, Leslie A Lange · 2021 to 2026
$5.2M
Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk ScoresU01CA261339 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fei Chen, David V Conti · 2021 to 2026
$5.2M
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry - Study SitesU01HG011717 · NHGRI · UNIVERSITY OF MARYLAND BALTIMORE · PI ADEBAMOWO, SALLY NNEOMA, TAYO, BAMIDELE OLUSEGUN · 2021 to 2025
$4.6M
Polygenic Risk of Disease in Populations of Diverse AncestryU01HG011710 · NHGRI · MAYO CLINIC ROCHESTER · PI SCHAID, DANIEL J. · 2021 to 2025
$3.2M
The influence of genetic ancestry and population-specific epidemiology on the transferability of genomic findings to diverse and admixed populationsR35HG011944 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI WOJCIK, GENEVIEVE LIANNE · 2021 to 2025
$2.3M
NCI NIH HHS U01 CA261339NHGRI NIH HHS R35 HG011944NHGRI NIH HHS U01 HG011697NHGRI NIH HHS U01 HG011710NHGRI NIH HHS U01 HG011715NHGRI NIH HHS U01 HG011717NHGRI NIH HHS U01 HG011719NHGRI NIH HHS U01 HG011720NHGRI NIH HHS U01 HG011723NHGRI NIH HHS U24 HG010262NHLBI NIH HHS T32 HL007111
6 · The paper itself

Abstract

Population descriptors used in genetic studies have broad social and translational implications. There are no globally agreed-upon definitions or usages of common population descriptors (e.g., race, ethnicity, nationality, and tribe), many of which are applied ad hoc and/or derived from political or bureaucratic conventions. Recent recommendations have encouraged the retention of as much granularity in population descriptors as possible during data preparation, analysis, and interpretation of research results. However, genomic research infrastructures (i.e., current practices, resources, and workflows in genomic research) often lack systematic and flexible organization, structure, and harmonization of multifaceted and detailed population descriptor data. This can lead to loss of information, barriers to international collaboration, and potential issues in clinical translation. Here, we describe a data model, developed by the NIH-funded Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium, that organizes and retains detailed population descriptor data for future research use. The model supports a versatile, traceable, and reproducible harmonization system that offers multiple benefits over existing data structures. This data model affords researchers the flexibility to thoughtfully choose and scientifically justify their choice of population descriptors. It avoids the conflation of social identities with biological categories and guards against harmful typological inferences. Genomic research tools of this kind will be crucial for producing scientifically robust findings that minimize potential harms of descriptor misuse while maximizing benefits for diverse communities.

Indexed as

Genetics, PopulationGenomicsHumansMultifactorial Inheritancedata modelgeneticsgenomicspopulation descriptors

Identifiers

PMID40513563
PMCPMC12256887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.